Minerva Neurosciences Statistics
Total Valuation
NERV has a market cap or net worth of $156.61 million. The enterprise value is $141.34 million.
| Market Cap | 156.61M |
| Enterprise Value | 141.34M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NERV has 47.75 million shares outstanding. The number of shares has increased by 260.56% in one year.
| Current Share Class | 47.75M |
| Shares Outstanding | 47.75M |
| Shares Change (YoY) | +260.56% |
| Shares Change (QoQ) | +80.19% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 68.38% |
| Float | 34.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.14
| Current Ratio | 20.14 |
| Quick Ratio | 19.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -28.42% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -31.32% |
| Weighted Average Cost of Capital (WACC) | 2.61% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$56.34M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.19% in the last 52 weeks. The beta is -0.12, so NERV's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | +56.19% |
| 50-Day Moving Average | 4.16 |
| 200-Day Moving Average | 5.06 |
| Relative Strength Index (RSI) | 32.94 |
| Average Volume (20 Days) | 157,050 |
Short Selling Information
The latest short interest is 2.42 million, so 5.07% of the outstanding shares have been sold short.
| Short Interest | 2.42M |
| Short Previous Month | 2.11M |
| Short % of Shares Out | 5.07% |
| Short % of Float | 7.06% |
| Short Ratio (days to cover) | 10.37 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.54M |
| Pretax Income | -394.35M |
| Net Income | -394.35M |
| EBITDA | -28.53M |
| EBIT | -28.54M |
| Earnings Per Share (EPS) | -$14.44 |
Balance Sheet
The company has $75.27 million in cash and $60.00 million in debt, with a net cash position of $15.27 million or $0.32 per share.
| Cash & Cash Equivalents | 75.27M |
| Total Debt | 60.00M |
| Net Cash | 15.27M |
| Net Cash Per Share | $0.32 |
| Equity (Book Value) | -201.56M |
| Book Value Per Share | -4.52 |
| Working Capital | 75.77M |
Cash Flow
| Operating Cash Flow | -26.17M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 5,442 |
| Net Borrowing | n/a |
| Free Cash Flow | -26.17M |
| FCF Per Share | -$0.55 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NERV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -260.56% |
| Shareholder Yield | -260.56% |
| Earnings Yield | -251.80% |
| FCF Yield | -16.71% |
Analyst Forecast
The average price target for NERV is $10.33, which is 214.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.33 |
| Price Target Difference | 214.94% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 21, 2022. It was a reverse split with a ratio of 1:8.
| Last Split Date | Jun 21, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |